J.C. Cerottini

Discipline

Histoire, Philosophie et Sociologie des sciences (2) Psychologie (1)

Type de document

Articles (20) Recensions (2)

Co-auteur

Date

Source

Mot-clé

T cells (15) Antigens (15) Human beings (14) Cells (12) Melanoma (10) Clones (9) Patients (8) Receptors (8) Patients (8) Peptides (7) cytotoxicité (6) Amino acid sequence (6) spectacle (5) membrane (5) analyse (5) ligne (5) Mice (5) Histocompatibility (5) Cancer (5) Animals (5) Analysis (5) Vaccination (4) Tumors (4) Proteins (4) Immunotherapy (4) Expression (4) Clone cells (4) Blood (4) Older people (4) Vaccination (4)

Documents écrit par J.C. Cerottini (20) | parle de J.C. Cerottini (0)

Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.
G. Bricard et al. (2009)
Immunogenicity of the carcinoembryonic antigen derived peptide 694 in HLA-A2 healthy donors and colorectal carcinoma patients.
P.M. Alves et al. (2007)
IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.
C. Barbey et al. (2007)
Tumor cell recognition efficiency by T cells.
D.E. Speiser et al. (2005)
Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.
G. Bricard et al. (2005)
Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination.
P. Romero et al. (2004)
Thymic selection generates a large T cell pool recognizing a self-peptide in humans.
A. Zippelius et al. (2002)
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans.
V. Dutoit et al. (2002)
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells
F. Berard et al.
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
M. J. Pittet et al.
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
D.E. Speiser et al. (1999)
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
D. Valmori et al. (1999)
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
D. Valmori et al. (1999)
Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
B.M. Kessler et al. (1997)
Role of CD8 in aberrant function of cytotoxic T lymphocytes.
B. Kessler et al. (1997)
Recognition of tumor-associated antigens by T-lymphocytes: perspectives for peptide-based vaccines.
J.C. Cerottini et al. (1996)
T cell receptor selection by and recognition of two class I major histocompatibility complex-restricted antigenic peptides that differ at a single position.
J.L. Casanova et al. (1993)
Differential T cell receptor photoaffinity labeling among H-2Kd restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. Labeling of the alpha-chain correlates with J alpha segment usage.
P. Romero et al. (1993)
The identification of tyrosine as a common key residue in unrelated H-2Kd restricted antigenic peptides
J. L. Maryanski et al.
Thymus-derived (T) cell immunoglobulins. Presence of a receptor site for IgG and absence of large amounts of "buried" Ig determinants on T cells
H. M. Grey et al.